Online vs Therapist-Directed Therapy for Insomnia with Sleep Apnea
Trial Summary
What is the purpose of this trial?
This two-site randomized clinical trial will investigate and compare three treatments for insomnia in patients who have been diagnosed with and treated for sleep apnea: online cognitive behavioral therapy (OCBT), therapist-directed cognitive behavioral therapy (TCBT), and standard clinical care. 384 patients will be recruited and will attend up to 15 visits over 10 months. Visits will include baseline assessment, treatment visits, and post-treatment follow-up visits. Visits will involve completion of questionnaires, meeting with therapists, and a physical exam.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are using medications known to cause insomnia, like stimulants.
What data supports the effectiveness of the treatment Online Cognitive Behavioral Therapy (OCBT) and Therapist-directed Cognitive Behavioral Therapy (TCBT) for insomnia with sleep apnea?
Research shows that online cognitive behavioral therapy for insomnia (OCBT-i) can improve sleep efficiency and reduce insomnia severity, making it a promising option for treating sleep issues. Additionally, both online and face-to-face cognitive behavioral therapies have been found effective in improving sleep in people with insomnia.12345
Is online or therapist-directed therapy for insomnia with sleep apnea safe?
How does the treatment for insomnia with sleep apnea differ from other treatments?
This treatment is unique because it offers cognitive behavioral therapy for insomnia (CBT-I) through online platforms, making it more accessible to patients who may not have access to trained therapists. The online version (OCBT) can be a first step, with more intensive therapist-directed therapy (TCBT) reserved for those who need additional support, which is a novel approach for managing insomnia with sleep apnea.13469
Eligibility Criteria
This trial is for adults over 21 with sleep apnea and mild insomnia, using PAP therapy for at least a month. They must have trouble sleeping despite having the chance to sleep well and feel daytime effects from poor sleep. Excluded are those with certain other sleep disorders, regular marijuana use after 4 PM, untreated major depression, recent substance abuse, or severe illnesses like cancer.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline assessments including questionnaires and physical exams
First-stage Treatment
Participants receive Online Cognitive Behavioral Therapy (OCBT) or usual care with PAP therapy and sleep hygiene education
Second-stage Treatment
Participants not meeting remission criteria are re-randomized to extended OCBT or Therapist-directed CBT (TCBT)
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Online Cognitive Behavioral Therapy (OCBT)
- Therapist-directed Cognitive Behavioral Therapy (TCBT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Jewish Health
Lead Sponsor
Stanford University
Collaborator